Use of Precision Medicine Molecular Profiling of Baseline Tumor Specimen May Not Benefit Outcomes in Children With Relapsed or Refractory Pediatric Sarcomas

J. Carter, Liang Cheng, J. Zucker, M. Marshall, Karen Pollok, M. Murray, L. Li, Jamie Renbarger

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)328-330
Number of pages3
JournalClinical Pharmacology and Therapeutics
Volume101
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Precision Medicine
Sarcoma
Pediatrics
Neoplasms

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

@article{47c0498a66a74081a5937c5decbea049,
title = "Use of Precision Medicine Molecular Profiling of Baseline Tumor Specimen May Not Benefit Outcomes in Children With Relapsed or Refractory Pediatric Sarcomas",
author = "J. Carter and Liang Cheng and J. Zucker and M. Marshall and Karen Pollok and M. Murray and L. Li and Jamie Renbarger",
year = "2017",
month = "3",
day = "1",
doi = "10.1002/cpt.599",
language = "English (US)",
volume = "101",
pages = "328--330",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Use of Precision Medicine Molecular Profiling of Baseline Tumor Specimen May Not Benefit Outcomes in Children With Relapsed or Refractory Pediatric Sarcomas

AU - Carter, J.

AU - Cheng, Liang

AU - Zucker, J.

AU - Marshall, M.

AU - Pollok, Karen

AU - Murray, M.

AU - Li, L.

AU - Renbarger, Jamie

PY - 2017/3/1

Y1 - 2017/3/1

UR - http://www.scopus.com/inward/record.url?scp=85012201479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012201479&partnerID=8YFLogxK

U2 - 10.1002/cpt.599

DO - 10.1002/cpt.599

M3 - Article

VL - 101

SP - 328

EP - 330

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 3

ER -